Canaccord Genuity Raises Doximity Price Target To $67, Maintains Hold

Group 1 - Canaccord Genuity raised its price target on Doximity Inc. to $67 from $59 while maintaining a Hold rating [1] - The rapid pace of change in the large language model environment is reshaping healthcare technology, with trust among users being critical for long-term success [1] - Doximity's position in the early stages of the AI transition could allow it to become one of the winners in the space [2] Group 2 - Despite the raised price target, Canaccord maintained its Hold stance due to current valuation levels [2]